Sort
40,608 grants matching “prostate cancer”
Cancer and Leukemia Group B - The Ohio State University
$402,122Ohio State University · U10 · FY2003 · CA
The use of chitosan for cancer vaccine delivery
$401,951John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Stanford Cancer Imaging Training (SCIT) Program
$401,901Jeremy Dahl · Stanford University · T32 · FY2025 · CA
Adhesion of Metastatic Tumor Cells in the Bloodstream
$401,884Michael R King · Cornell University · U54 · FY2010 · CA
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
$401,719Ying Huang · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
$401,718Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Small Molecule PSMA-Targeted Alpha Therapy
$401,678Martin G Pomper · Johns Hopkins University · R01 · FY2018 · CA
Molecular Analysis of Steroid Hormone Receptors with X-ray Crystallography
$401,629Kendall W Nettles · Scripps Research Institute, The · R33 · FY2009 · CA
Prostatitis and Prostate Cancer Development
$401,608Lawrence Fong · University Of California, San Francisco · R01 · FY2014 · CA
Prostatectomy vs watchful waiting - a randomized trial.
$401,524Gunnar Steineck · Karolinska Institute · R01 · FY2007 · CA
Immune activation by necroptotic cell death
$401,522Andrew Atwell Oberst · University Of Washington · R01 · FY2023 · CA
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression
$401,472Jay H Fowke · Vanderbilt University · R01 · FY2010 · DK
Breast and Prostate Cancer Patterns of Care
$401,457Rosemary Cress · Public Health Institute · U01 · FY2006 · DP
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2015 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2016 · CA
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$401,430Craig Lee Slingluff · University Of Virginia · U01 · FY2013 · CA
Rel B mediated-redox regulation of radiation therapy
$401,390Daret K St Clair · University Of Kentucky · R01 · FY2011 · CA
Erythropoietin Blockade for the Treatment of Cancer
$401,386C. Anthony Blau · University Of Washington · R01 · FY2011 · CA
Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC)
$401,363Zhi-Ping Liu · Ut Southwestern Medical Center · R01 · FY2019 · CA
Molecular and Computational Tools for Identifying Somatic Mosaicism in Human Tissues
$401,347Ryan E Mills · University Of Michigan At Ann Arbor · UG3 · FY2023 · NS
Early Detection of Ovarian Cancer Through Epigenetic Factors in the WHI
$401,317Jeanine M. Genkinger · Columbia University Health Sciences · R01 · FY2016 · CA
Elucidating the Mechanisms of Racial and Ethnic Disparities in Dialysis Quality
$401,305Eugene Lin · University Of Southern California · R01 · FY2025 · DK
Radiation Force Imaging of Prostate Cancer and Guidance of Biopsy Procedures
$401,277Kathryn R Nightingale · Duke University · R01 · FY2011 · CA
Androgen receptor pathway inhibition through targeting PARP-2 in castration-resistant prostate cancer
$401,273Li Jia · Brigham And Women'S Hospital · R01 · FY2022 · CA